Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TRIM35 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | SESN1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SDHD | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ZNF32 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ATP5L | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | CCR7 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ZNF221 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | USP31 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | MRPS24 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | FAM168B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |